title: 3T3-L1 adipocytes induce dysfunction of MIN6 insulin-secreting cells via multiple pathways mediated by secretory factors in a co-culture system.
abstract: Pancreatic beta-cell dysfunction is an important pathological change in type 2 diabetes, which is tightly related to obesity. However, the direct role of adipose tissue in beta-cell dysfunction has not been well understood. In this study, we examined the effects of 3T3-L1 adipocytes on MIN6 insulin-secreting cells in a co-culture system. MIN6 cells used here kept most of beta-cell functions but less sensitive to glucose stimulation. Tolbutamide, the KATP channel blocker, was therefore used to stimulate insulin secretion in this report. MIN6 cells co-cultured with 3T3-L1 adipocytes had significantly reduced intracellular calcium concentration ([Ca2+]i) and lost the ability to secrete insulin in response to tolbutamide, compared to the control cells. 3T3-L1 adipocytes significantly decreased the expression of insulin, glucokinase and Kir6.2 genes but increased the expression of uncoupling protein-2 (UCP-2) in MIN6 cells after one week of co-culture, as measured by semi-quantitative RT-PCR. 3T3-L1 adipocyte-conditioned medium also significantly decreased insulin secretion and the expression of insulin, glucokinase and Kir6.2 genes in MIN6 cells. The conditioned medium also reduced tyrosine kinase activity in MIN6 cells. The inhibitor of protein tyrosine kinase, genistein, decreased the expression of glucokinase and Kir6.2 in MIN6 cells, while two free fatty acids, oleic acid and linoleic acids, were found to increase UCP-2 expression. The present study demonstrates that 3T3-L1 adipocytes directly impair insulin secretion and the expression of important genes in MIN6 cells. The effects of T3-L1 adipocytes on MIN6 cells are ascribed to secreted bioactive factors and may be mediated via multiple pathways, which include the upregulation of UCP-2 expression via free fatty acids, and downregulation of glucokinase and Kir6.2 expression via decreasing protein tyrosine kinase activity.
authors: Prince Henry's Institute of Medical Research, Clayton, VIC, 3168, Australia.
authors: Yu-Feng
authors: YF
authors: Zhao
authors: Dan-Dan
authors: DD
authors: Feng
authors: Maria
authors: M
authors: Hernandez
authors: Chen
authors: C
authors: Chen
mesh_terms: D041721:3T3-L1 Cells; D017667:Adipocytes / Q000378:metabolism* / Q000502:physiology; D000818:Animals; D002118:Calcium / Q000378:metabolism; D018920:Coculture Techniques; D017077:Culture Media, Conditioned; D005230:Fatty Acids, Nonesterified / Q000502:physiology; D015870:Gene Expression; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D050417:Insulin-Secreting Cells / Q000378:metabolism / Q000502:physiology*; D051379:Mice; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism; D015398:Signal Transduction / Q000502:physiology
chemical_list: D017077:Culture Media, Conditioned; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D011505:Protein-Tyrosine Kinases; D002118:Calcium
references: Am J Physiol Endocrinol Metab. 2002 Aug;283(2):E207-16
references: 12110524
references: Endocrinology. 2002 Apr;143(4):1371-7
references: 11897694
references: Cell. 2001 Jun 15;105(6):745-55
references: 11440717
references: Annu Rev Med. 1996;47:69-83
references: 8712804
references: Diabetologia. 1993 Nov;36(11):1139-45
references: 8270128
references: Metabolism. 2001 May;50(5):613-8
references: 11319727
references: Recent Prog Horm Res. 2001;56:195-217
references: 11237213
references: Diabetes. 1999 May;48(5):1020-5
references: 10331406
references: Life Sci. 1994;55(6):413-22
references: 8035658
references: Biochem Biophys Res Commun. 1996 Jul 16;224(2):522-7
references: 8702421
references: Nature. 1991 Oct 10;353(6344):558-60
references: 1656271
references: Am J Med. 2000 Apr 17;108 Suppl 6a:2S-8S
references: 10764844
references: Diabetes. 1990 Jun;39(6):647-52
references: 2189759
references: J Biol Chem. 2000 Dec 8;275(49):38281-5
references: 10995763
references: Trends Endocrinol Metab. 2000 Nov;11(9):351-6
references: 11042464
references: Diabetes. 2001 Feb;50(2):315-21
references: 11272142
references: Diabetes. 2001 Apr;50(4):803-9
references: 11289045
references: Annu Rev Physiol. 1998;60:667-87
references: 9558481
references: Endocrinology. 2002 Feb;143(2):339-42
references: 11796484
references: Endocr Rev. 1992 Aug;13(3):415-31
references: 1425483
references: Diabetes. 2001 Feb;50 Suppl 1:S146-9
references: 11272177
references: J Biol Chem. 2003 Mar 28;278(13):11303-11
references: 12496284
references: Biotechniques. 1990 Dec;9(6):711-3
references: 1702975
references: J Clin Invest. 1998 Mar 1;101(5):1094-101
references: 9486980
references: Br Med Bull. 1997;53(2):322-40
references: 9246839
references: Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):10878-82
references: 7971976
references: Diabetes. 1999 Jul;48(7):1482-6
references: 10389858
references: Diabetologia. 1997 Nov;40(11):1367-8
references: 9389434
references: J Mol Endocrinol. 2005 Aug;35(1):49-59
references: 16087721
references: Am J Physiol Endocrinol Metab. 2001 Jun;280(6):E827-47
references: 11350765
references: Biochem Biophys Res Commun. 2003 Dec 26;312(4):1118-22
references: 14651988
references: Diabetes. 1995 Aug;44(8):863-70
references: 7621989
references: Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10402-6
references: 9724715
references: Nature. 2003 Mar 13;422(6928):173-6
references: 12629551
references: Biochim Biophys Acta. 1998 Jun 10;1365(1-2):319-27
references: 9693744
references: Diabetes. 1995 Dec;44(12):1447-57
references: 7589853
references: Diabetes Metab. 1996 Feb;22(1):7-14
references: 8697299
references: Sheng Li Xue Bao. 2004 Apr 25;56(2):253-7
references: 15127139
references: Acta Clin Belg. 2000 Jan-Feb;55(1):9-15
references: 10783502